The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, David R. Martinez, Rajendra Raut, Alena Markmann, Caleb Cornaby, Luther Bartelt, Susan Weiss, Yara Park, Caitlin E. Edwards, Eric Weimer, Erin M. Scherer, Nadine Roupael, Sri Edupuganti, Daniela Weiskopf, Longping V. Tse, Yixuan J. Hou, David Margolis, Alessandro Sette, Matthew H. Collins, John Schmitz, Ralph S. Baric, Aravinda M. de Silva
doi: https://doi.org/10.1101/2020.05.06.20093377
Lakshmanane Premkumar
1Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Bruno Segovia-Chumbez
1Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Ramesh Jadi
1Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
David R. Martinez
2Department of Epidemiology, UNC Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Rajendra Raut
1Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Alena Markmann
3Departments of Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Caleb Cornaby
5Immunology/Histocompatibility and Immunogenetics Laboratories, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Luther Bartelt
3Departments of Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Susan Weiss
3Departments of Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Yara Park
3Departments of Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Caitlin E. Edwards
2Department of Epidemiology, UNC Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Eric Weimer
4Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Erin M. Scherer
8Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, Decatur, Georgia, USA
Nadine Roupael
8Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, Decatur, Georgia, USA
Sri Edupuganti
8Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, Decatur, Georgia, USA
Daniela Weiskopf
6Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA
Longping V. Tse
2Department of Epidemiology, UNC Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Yixuan J. Hou
2Department of Epidemiology, UNC Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
David Margolis
1Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
2Department of Epidemiology, UNC Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
3Departments of Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Alessandro Sette
6Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA
7Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA
Matthew H. Collins
8Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, Decatur, Georgia, USA
John Schmitz
4Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Ralph S. Baric
1Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
2Department of Epidemiology, UNC Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Aravinda M. de Silva
1Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Article usage
Posted May 10, 2020.
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, David R. Martinez, Rajendra Raut, Alena Markmann, Caleb Cornaby, Luther Bartelt, Susan Weiss, Yara Park, Caitlin E. Edwards, Eric Weimer, Erin M. Scherer, Nadine Roupael, Sri Edupuganti, Daniela Weiskopf, Longping V. Tse, Yixuan J. Hou, David Margolis, Alessandro Sette, Matthew H. Collins, John Schmitz, Ralph S. Baric, Aravinda M. de Silva
medRxiv 2020.05.06.20093377; doi: https://doi.org/10.1101/2020.05.06.20093377
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, David R. Martinez, Rajendra Raut, Alena Markmann, Caleb Cornaby, Luther Bartelt, Susan Weiss, Yara Park, Caitlin E. Edwards, Eric Weimer, Erin M. Scherer, Nadine Roupael, Sri Edupuganti, Daniela Weiskopf, Longping V. Tse, Yixuan J. Hou, David Margolis, Alessandro Sette, Matthew H. Collins, John Schmitz, Ralph S. Baric, Aravinda M. de Silva
medRxiv 2020.05.06.20093377; doi: https://doi.org/10.1101/2020.05.06.20093377
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (658)
- Anesthesia (177)
- Cardiovascular Medicine (2573)
- Dermatology (218)
- Emergency Medicine (390)
- Epidemiology (12090)
- Forensic Medicine (10)
- Gastroenterology (743)
- Genetic and Genomic Medicine (3995)
- Geriatric Medicine (376)
- Health Economics (667)
- Health Informatics (2578)
- Health Policy (992)
- Hematology (357)
- HIV/AIDS (825)
- Medical Education (396)
- Medical Ethics (107)
- Nephrology (423)
- Neurology (3759)
- Nursing (206)
- Nutrition (559)
- Oncology (1958)
- Ophthalmology (569)
- Orthopedics (233)
- Otolaryngology (301)
- Pain Medicine (247)
- Palliative Medicine (72)
- Pathology (469)
- Pediatrics (1088)
- Primary Care Research (442)
- Public and Global Health (6429)
- Radiology and Imaging (1366)
- Respiratory Medicine (859)
- Rheumatology (394)
- Sports Medicine (336)
- Surgery (431)
- Toxicology (51)
- Transplantation (184)
- Urology (164)